FDA Panel Set to Review Moderna mRNA Flu Shot

The U.S. Food and Drug Administration's (FDA) vaccine advisory panel is scheduled to review Moderna's mRNA flu vaccine candidate. This review precedes a significant meeting slated for Thursday, where Moderna is seeking traditional approval for its vaccine. Reports suggest that FDA vaccine advisors have shown receptiveness towards the candidate.

By Fainaron·Jun 17, 2026 (an hour ago)·2 views

FDA Panel Set to Review Moderna mRNA Flu Shot

A U.S. Food and Drug Administration (FDA) vaccine advisory panel is poised to review Moderna's mRNA flu shot candidate. The company is seeking traditional approval for this specific vaccine.

This review is set to occur ahead of a key meeting scheduled for Thursday. FDA vaccine advisors have reportedly indicated an openness to Moderna’s candidate for an mRNA flu vaccine.

According to The Hill, the panel will assess the candidate as Moderna pursues traditional approval.

#fda #moderna #mrna #flu vaccine #vaccine panel #health #pharmaceutical

Source attribution: This article was AI-curated and rewritten by Fainaron from a piece originally published by The Hill. Read the original at The Hill →

More like this

Psychologists Report Patients Using AI in Therapy

Health

an hour ago

Psychologists Report Patients Using AI in Therapy

A recent survey by the American Psychological Association (APA) indicates that over one-third of psychologists have observed patients incorporating artificial intelligence (AI) into their mental health routines. This practice, where AI is used as an additional mental health professional, raises concerns among clinicians about the technology's potential to reinforce patient delusions.

Decrypt Crypto

Health

an hour ago

Bone Health Requires More Than Just Calcium, Expert Notes

A bone health expert has emphasized that maintaining strong bones throughout the aging process necessitates more than just daily calcium intake. This perspective suggests a broader approach is essential for comprehensive skeletal health, extending beyond a single nutrient.

Vogue

FDA Approves Second Fly Species for Maggot Wound Therapy

Health

2 hours ago

FDA Approves Second Fly Species for Maggot Wound Therapy

The U.S. Food and Drug Administration (FDA) has approved a second species of carcass-feeding fly for use in maggot wound therapy, a medical practice also known as biosurgery or maggot debridement therapy (MDT). This clearance was announced by Cuprina Holdings, a Singapore-based company, for its new therapeutic larvae, named MediFly Maggots. This approval makes Cuprina the only company with FDA clearance to market two different fly species for such treatments, potentially expanding options in the global market.

Ars Technica

Health

2 hours ago

Cannabis Commercialization Linked to Increased Usage and Mental Health Issues, Study Finds

An international review has found that the commercial sale of cannabis is associated with a rise in the number of users and an increase in mental health problems, including psychosis. Conversely, the decriminalization of cannabis possession or strict regulatory approaches did not appear to drive up usage rates. The study analyzed global shifts in cannabis policies over a 25-year period.

The Guardian World

Back to Homepage

FDA Panel Set to Review Moderna mRNA Flu Shot

More like this

Psychologists Report Patients Using AI in Therapy

Bone Health Requires More Than Just Calcium, Expert Notes

FDA Approves Second Fly Species for Maggot Wound Therapy

Cannabis Commercialization Linked to Increased Usage and Mental Health Issues, Study Finds

Fainaron — live counters